Inflammatory bowel disease: Genetic or environmental diseases?;Maladies inflammatoires chroniques de l'intestin : maladies génétiques ou de l'environnement ?

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 8-9, 2009, Pages 681-691

  Cortot, A ^a,b   Pineton de Chambrun, G ^a   Vernier Massouille, G ^a,b   Vigneron, B ^a   Gower Rousseau, C ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

APPENDECTOMY; AUTOPHAGY; DEVELOPING COUNTRY; DIZYGOTIC TWINS; ENTERITIS; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FOOD COMPOSITION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYGIENE; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE FLORA; MONOZYGOTIC TWINS; MUCOSAL IMMUNITY; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; POLLUTION; PREVALENCE; SHORT SURVEY; SMOKING;

EID: 70349169554     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.07.005     Document Type: Short Survey

References (76)

1. Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126 (2004) 1504-1517
2. Podolsky D.K. Inflammatory Bowel Disease. N Engl J Med 347 (2002) 417-429
3. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134 (2008) 577-594
4. Calkins B.M. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34 (1989) 1841-1854
5. Andersson R.E., Olaison G., Tysk C., and Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med 344 (2001) 808-814
6. Orholm M., Munkholm P., Langholz E., Nielsen O.H., Sørensen T.I., and Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 324 (1991) 84-88
7. Tysk C., Lindberg E., Jarnerot G., and Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29 (1988) 990-996
8. Loftus C.G., Loftus Jr. E.V., Harmsen W.S., Zinsmeister A.R., Tremaine W.J., Melton III L.J., et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 13 (2007) 254-261
9. Molinie F., Gower-Rousseau C., Yzet T., Merle V., Grandbastien B., Marti R., et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 53 (2004) 843-848
10. Blanchard J.F., Bernstein C.N., and Wajda A. Small area variations socio-demographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 154 (2001) 328-335
11. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39 (1996) 690-697
12. Ogunbi S.O., Ransom J.A., Sullivan K., Schoen B.T., and Gold B.D. Inflammatory bowel disease in African-American children living in Georgia. J Pediatr 133 (1998) 103-107
13. Nerich V., Monnet E., Etienne A., Louafi S., Ramee C., Rican S., et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 12 (2006) 218-226
14. Declercq C., Gower-Rousseau C., Vernier-Massouille G., Salleron J., Baldé M., Poirier G., et al. Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence (abstract). Gastroenterology 132 (2007) M1016
15. Laharie D., Debeugny S., Peeters M., Van Gossum A., Gower-Rousseau C., Belaiche J., et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 120 (2001) 816-819
16. Gilat T., Grossman A., Fireman Z., and Rosen P. Inflammatory bowel diseases in Jews. In: McConnell R., Rozen P., Langman M., and Gilat T. (Eds). The genetics and epidemiology of inflammatory bowel disease. (1986), Karger, Basel 135-140
17. Fireman Z., Grossman A., Lilos P., Eshchar Y., Theodor E., and Gilat T. Epidemiology of Crohn's disease in the Jewish population of central Israel, 1970-1980. Am J Gastroenterol 84 (1989) 255-258
18. Probert C.S., Jayanthi V., Pinder D., Wicks A.C., and Mayberry J.F. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 33 (1992) 687-693
19. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 18 (2004) 481-496
20. Halfvarson J., Bodin L., Tysk C., Lindberg E., and Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124 (2003) 1767-1773
21. Cosnes J., Beaugerie L., Carbonnel F., and Gendre J.P. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 120 (2001) 1093-1099
22. Bernstein C.N., and Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 57 (2008) 1185-1191
23. Cosnes J., Carbonnel F., Beaugerie L., Blain A., Reijasse D., and Gendre J.P. Effects of appendicectomy on the course of ulcerative colitis. Gut 51 (2002) 803-807
24. Andersson R.E., Olaison G., Tysk C., and Ekbom A. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 124 (2003) 40-46
25. Koutroubakis I.E., Vlachonikolis I.G., and Kouroumalis E.A. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 8 (2002) 277-286
26. Cornish J.A., Tan E., Simillis C., Clark S.K., Teare J., and Tekkis P.P. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 103 (2008) 2394-2400
27. Cosnes J., Carbonnel F., Carrat F., Beaugerie L., and Gendre J.P. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 45 (1999) 218-222
28. Russel M.G., Engels L.G., Muris J.W., Limonard C.B., Volovics A., Brummer R.J., et al. Modern life in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 10 (1998) 243-249
29. Ekbom A., and Montgomery S.M. Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Pract Res Clin Gastroenterol 18 (2004) 497-508
30. Jarnerot G., Jarnmark I., and Nilsson K. Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 18 (1983) 999-1002
31. Riordan A.M., Ruxton C.H., and Hunter J.O. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 52 (1998) 229-238
32. Sakamoto N., Kono S., Wakai K., Fukuda Y., Satomi M., Shimoyama T., et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 11 (2005) 154-163
33. Baron S., Turck D., Leplat C., Merle V., Gower-Rousseau C., Marti R., et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population-based case control study. Gut 54 (2005) 357-363
34. Aamodt G., Bukholm G., Jahnsen J., Moum B., and Vatn M.H. The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway. Am J Epidemiol 168 (2008) 1065-1072
35. Lerebours E., Gower-Rousseau C., Merle V., Brazier F., Debeugny S., Salomez J.L., et al. Stressful life events as a risk factor for inflammatory bowel disease onset: a population-based case-control study. Am J Gastroenterol 102 (2007) 122-131
36. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347 (2002) 911-920
37. Wurzelmann J.I., Lyles C.M., and Sandler R.S. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci 39 (1994) 555-560
38. Klement E., Cohen R.V., Boxman J., Joseph A., and Reif S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr 80 (2004) 1342-1352
39. Ekbom A., Wakefield A.J., Zack M., and Adami H.O. Perinatal measles infection and subsequent Crohn's disease. Lancet 344 (1994) 508-510
40. Morris D.L., Montgomery S.M., Thompson N.P., Ebrahim S., Pounder R.E., and Wakefield A.J. Measles vaccination and inflammatory bowel disease: a national British Cohort Study. Am J Gastroenterol 95 (2000) 3507-3512
41. Behr M.A., and Schurr E. Mycobacteria in Crohn's disease: a persitent hypothesis. Inflamm Bowel Dis 12 (2006) 1000-1004
42. Selby W., Pavli P., Crotty B., Florin T., Radford-Smith G., Gibson P., et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 132 (2007) 2313-2319
43. Pinedo P.J., Buergelt C.D., Donovan G.A., Melendez P., Morel L., Wu R., et al. Association between CARD15/NOD2 gene polymorphism and paratuberculosis infection in cattle. Vet Microbiol 134 (2009) 346-352
44. Ahmad T., Tamboli C.P., Jewell D., and Colombel J.F. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 126 (2004) 1533-1549
45. Colombel J.F., Grandbastien B., Gower-Rousseau C., Plegat S., Evrard J.P., Dupas J.L., et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 111 (1996) 604-607
46. Sendid B., Quinton J.F., Charrier G., Goulet O., Cortot A., Grandbastien B., et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 93 (1998) 1306-1310
47. Sandberg-Gertzén H., Eid R., and Järnerot G. Hermansky-Pudlak syndrome with colitis and pulmonary fibrosis. Scand J Gastroenterol 34 (1999) 1055-1056
48. Lloyd-Still J.D. Crohn's disease and cystic fibrosis. Dig Dis Sci 39 (1994) 880-885
49. Buzaglo G., Gonzalez F., Wauquier N., Gower-Rousseau C., Vermersch P., and Colombel J.F. Concurrence of inflammatory bowel disease and multiple sclerosis. Clinical course and phenotypes (abstract). Gut 57 Suppl. 2 (2008) A57
50. Gaya D.R., Russell R.K., Nimmo E.R., and Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases?. Lancet 367 (2006) 1271-1284
51. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
52. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
53. Lesage S., Zouali H., Cézard J.P., Colombel J.F., Belaiche J., Almer S., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70 (2002) 845-857
54. Rioux J.D., Daly M.J., Silverberg M.S., Lindblad K., Steinhart H., Cohen Z., et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn's disease. Nat Gent 29 (2001) 223-228
55. Cho J.H., and Weaver C.T. The genetics of inflammatory bowel disease. Gastroenterology 133 (2007) 1327-1339
56. Mathew C.G. New links to the pathogenesis of Crohn's disease provided by genome-wide association scans. Nat Rev Genet 9 (2008) 9-14
57. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn's disease in ATG16L1. Nat Genet 39 (2007) 207-211
58. Parkes M., Barett J.C., Prescott N.J., Tremelling M., Anderson C.A., Fisher S.A., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39 (2007) 830-832
59. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., et al. Genome-wide association study identifies new susceptibility loci for Crohn's disease and implicates autophagy in disease pathogenesis. Nat Genet 39 (2007) 596-604
60. The Wellcome trust Case-Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 2007;447:661-78.
61. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
62. Libioulle C., Louis E., Hansoul S., Sandor C., Farnir F., Franchimont D., et al. A novel susceptibility locus for Crohn's disease identified by whole genome association maps to a gene desert on chromosome 5p13.1 and modulate expression of PTGER4. PLoS Genet 3 (2007) e58
63. Yamazaki K., McGovern D., Ragoussis J., Paolucci M., Butler H., Jewell D., et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet (2005) 3499-3506
64. Franke A., Hampe J., Rosenstiel P., Becker C., Wagner F., Häsler R., et al. Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS ONE 2 (2007) e691
65. Raelson J.V., Little R.D., Ruether A., Fournier H., Paquin B., Van Eerdewegh P., et al. Genome-wide association study for Crohn's disease in the Quebec founder population identifies multiple validated disease loci. Proc Natl Acad Sci U S A 104 (2007) 14747-14752
66. Fisher S.A., Tremelling M., Anderson C.A., Gwilliam R., Bumpstead S., Prescott N.J., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 40 (2008) 710-712
67. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 40 (2008) 713-715
68. Anderson C.A., Massey D.C.O., Barett J.C., Prescott N.J., Tremelling M., Fisher S.A., et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 136 (2009) 523-529
69. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40 (2008) 955-962
70. Packey C.D., and Sartor R.B. Interplay of commensal and pathogenic bacteria, genetic mutations and immunoregulatory defects in the pathogenesis of inflammatory bowel disease. J Intern Med 263 (2008) 597-606
71. Wehkamp J., Schmid M., and Stange E.F. Defensins and other anti-microbial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 23 (2007) 370-378
72. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L.G., Gratadoux J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn's disease patients. Proc Natl Acad Sci U S A 105 (2008) 16731-16736
73. Feller M., Huwiler K., Stephan R., Altpeter E., Shang A., Furrer H., et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 7 (2007) 607-613
74. Darfeuille-Michaud A., Boudeau J., Bulois P., Neut C., Glasser A.L., Barnich N., et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127 (2004) 412-421
75. Barnich N., Carvalho F.A., Glasser A.L., Darcha C., Jantscheff P., Allez M., et al. CEACAM6 acts as a receptor of adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn's disease. J Clin Invest 117 (2007) 1566-1574
76. Frank D.N., and Pace N.R. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol 24 (2008) 4-10